Press Releases - 2007 Archive

MIRAMAR, Fla.- Azopharma…announced today the opening of a new Cyanta Analytical Laboratories facility…equipped with state-of-the-art instrumentation to support pharmaceutical and medical device product development, specifically analytical method development…

MIRAMAR, Fla.- “We are very excited about our new facilities and completed expansion…Phase I Express® process allows for timely execution of formulation development from lab scale prototypes to Phase I clinical trial materials. The expansion…will significantly increase…”

MIRAMAR, Fla.- Azopharma…announced today the launch of two new companies to become part of the Azopharma…Group of companies. The new additions are ApiCross Drug Delivery Technologies and AvivoClin Clinical Services…“With these two additions…we can now provide the…”

MIRAMAR, Fla. - Phase I Express offers formulation development support from preformulation evaluation to the manufacture of clinical supplies. Phase I Express includes preformulation, formulation, analytical R&D, QC release, stability, manufacturing….of Clinical Supplies for Phase I development….

MIRAMAR, Fla.- Azopharma has reached an agreement to purchase certain facility assets and assume occupation of a research and development facility in Hollywood, Florida, previously operated by Kos Pharmaceuticals…“We are pleased about the addition…

MIRAMAR, Fla.- Azopharma announces a European branch…“Pharmaceutical companies in Europe now have local representation to facilitate access to the compelling solutions in contract drug development services offered by our group of companies”…

MIRAMAR, Fla.- Azopharma is proud to announce newly established relationships with IQsynthesis and Cyanta..."These two additions...will round out our service offering portfolio and enhance our position....We are now poised to capitalize on..."

MIRAMAR, Fla.- … “With the needs of our clients in mind it is with great excitement that we are able to announce the acquisition of an USDA licensed and AAALAC accredited CRO facilities that offer services that will enable flexible and more rapid study starts for both discovery…”